July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled clinical TIMELY trial. The TIMELY study investigates to what extent the AI-supported TIMELY platform improves the health of myocardial infarction (MI) patients and other patients with coronary heart disease after cardiac rehabilitation. 

July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized controlled trial (RCT), which were presented by principal investigator Dr. Koen Deloose at LINC, the Leipzig Interventional Course 2023.

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the closure of perimembranous ventricular septal defect (VSD). The advancements in trancatheter VSD closure have significantly contributed to its widespread adoption. Traditionally, VSD occluders are often made of shape memory alloys, such as nitinol.

Anne Snowdon, RN, PhD, FAAN

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid and comprehensive care to hundreds of heart patients every year for life-threatening emergencies and scheduled cardiac procedures.

July 13, 2023 — Elixir Medical, a developer of breakthrough cardiovascular technologies, announced enrollment completion in

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.

During the AIMed 2023 Summit, a panel of experts shared their personal perspective on what’s happening in artificial intelligence (AI), particularly with ChatGPT, and where they think these advances are going, in a panel discussion titled AI Foundations: 2023 Update of AI in Healthcare.

Controversies & Advances in the Treatment of Cardiovascular Disease, the Twenty-First in the Series

To move forward in artificial intelligence, it is critical for the medical community to learn to look at solutions in multiple ways to develop a deeper sense of duality

The 2023 AIMed Global Summit focused on artificial intelligence (AI) in healthcare, and offered valuable insights into the latest use cases, perspectives and novel approaches in healthcare AI. The event took place June 4-7 at the San Diego Convention Center in San Diego, Calif.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now